What place does ceftolozane/tazobactam have in the treatment of complicated urinary-tract infections?

Rita Murri; Emilio Sacco

doi:10.1080/14656566.2021.1915286

What place does ceftolozane/tazobactam have in the treatment of complicated urinary-tract infections?

Rita Murri^*
, Emilio Sacco

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

No abstract available

Lingua originale	Inglese
pagine (da-a)	1377-1379
Numero di pagine	3
Rivista	Expert Opinion on Pharmacotherapy
Volume	22
Numero di pubblicazione	11
DOI	https://doi.org/10.1080/14656566.2021.1915286
Stato di pubblicazione	Pubblicato - 2021

All Science Journal Classification (ASJC) codes

Farmacologia
Farmacologia (medica)

Keywords

Ceftolozane/tazobactam
Pseudomonas aeruginosa
complicated urinary tract infections
extended-spectrum beta-lactamases (ESBL)-producers

Accesso al documento

10.1080/14656566.2021.1915286

Altri file e collegamenti

Cita questo

@article{a9352621e9d0467285a3b9e7072f03c5,

title = "What place does ceftolozane/tazobactam have in the treatment of complicated urinary-tract infections?",

abstract = "No abstract available",

keywords = "Ceftolozane/tazobactam, Pseudomonas aeruginosa, complicated urinary tract infections, extended-spectrum beta-lactamases (ESBL)-producers, Ceftolozane/tazobactam, Pseudomonas aeruginosa, complicated urinary tract infections, extended-spectrum beta-lactamases (ESBL)-producers",

author = "Rita Murri and Emilio Sacco",

year = "2021",

doi = "10.1080/14656566.2021.1915286",

language = "English",

volume = "22",

pages = "1377--1379",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "-London United Kingdom:Informa Healthcare -London , United Kingdom: Ashley Publications Limited",